NDC 70000-0239-01 - Leader Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0239
- Requested NDC
- 70000-0239-01
- Package NDCs from labels
- 70000-0239-1, 70000-0239-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Leader Ibuprofen - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-08-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0239-1 | Leader Ibuprofen | 24 in 1 BOTTLE | TABLET, CHEWABLE | 24 | 5 | |
| 70000-0239-1 | Leader Ibuprofen | 1 in 1 CARTON | TABLET, CHEWABLE | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0239 | LEADER IBUPROFEN (IBUPROFEN) TABLET, CHEWABLE [CARDINAL HEALTH 110, LLC. DBA LEADER] | 4 | Current NDC, Legacy NDC, 2 package rows | 20210624_5975c324-2906-4e71-9b88-2e772d9fbfde.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0239-1 | EA - Each | 70000-0239 | 7c50a956-641c-49d0-977d-2f9de47410d7 | 1 | 2017-11-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | 3b9fdc48-c071-4e2c-e063-6294a90a679f | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Schuessler Tissue Salts Silica Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | f70dcf90-bde9-404d-9ede-4113553ccbff | 2025-08-04 | Warnings | ETJ7Z6XBU4 |
| CHILDRENS IBUPROFEN | IBUPROFEN | Meijer, Inc. | eed4f13d-4bee-4ccc-a651-a6f86d6d1f7b | 2025-08-04 | Warnings | ANDA076359 310963 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Asclemed USA, Inc. | d7ed42c4-371c-4a54-ab15-0630656f0427 | 2025-08-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PHOENIX RX LLC | 3b17587e-b609-42a9-e063-6294a90ab1f8 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | PAI Holdings, LLC dba PAI Pharma | c26cefe0-182a-4b03-baeb-b3eb2e0e2267 | 2025-08-01 | Warnings | WK2XYI10QM |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Preferred Pharmaceuticals Inc. | e2f29ca9-9ec8-4b82-8c80-8628d9e3ab2f | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Acetaminophen, Ibuprofen | ACETAMINOPHEN, IBUPROFEN | GLENMARK THERAPEUTICS INC., USA | 57a8dc2b-a3bc-49fa-b605-2330155bdbff | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 0e95aab9-3a7c-49c3-b8df-f66d6f31aee0 | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | 47657d95-4a54-49c2-8273-86b413b8f41e | 2025-07-30 | Warnings | WK2XYI10QM |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | ETJ7Z6XBU4 |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Clinolipid | OLIVE OIL AND SOYBEAN OIL | Baxter Healthcare Corporation | ae98eb03-c0e7-49d1-b024-77968e3d9d6e | 2025-07-24 | Warnings, Adverse reactions | 241ATL177A |
| Childrens Ibuprofen | IBUPROFEN | Publix Super Markets Inc | 54ae0273-4d8d-4c3b-85ff-675ba96f00de | 2025-07-22 | Warnings | ANDA076359 310963 WK2XYI10QM |
| ADVIL SINUS CONGESTION AND PAIN | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | b1e29c19-fe03-4d2b-b966-0adf4eb4b4cf | 2025-07-22 | Warnings | WK2XYI10QM |
| INFANTS IBUPROFEN | IBUPROFEN | Safeway | 6fed7c65-69a3-4899-a85d-23ea95f571a4 | 2025-07-21 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | SOLA Pharmaceuticals, LLC | 44fb0842-c34e-477e-96df-350cd5d6800e | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Consortium | 6c593a9c-680e-4645-8e8f-d8d044c92ca1 | 2025-07-18 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.